Thursday 24 January | |
Anglo American | Full Year Production |
Blue Prism | Full Year Results |
Restaurant Group | Trading Statement |
NCC Group | Trading Statement |
EMIS Group | Trading Statement |
Benchmark Holdings | Full Year Results |
CMC Markets | Trading Statement |
KAZ Minerals | Full Year Production |
Daily Mail & General Trust | Trading Statement |
Haynes Publishing | Trading Statement |
ITE Group | Trading Statement |
Kier Group | Trading Statement |
St James's Place | Trading Statement |
Fevertree Drinks | Trading Statement |
Friday 25 January | |
Bonmarche | Trading Statement |
AG Barr | Trading Statement |
Vodafone Group | Q3 Results |
Aberforth Smaller Cos | Full Year Results |
Monday 28 January | |
Petra Diamonds | Trading Statement |
SThree | Full Year Results |
Porvair | Full Year Results |
Paragon Banking Group | Trading Statement |
Tuesday 29 January | |
Hargreaves Lansdown | Half Year Results |
UDG Healthare | Trading Statement |
Royal Mail | Trading Statement |
Crest Nicholson Holdings | Full Year Results |
Domino's Pizza | Trading Statement |
Filtronic | Half Year Results |
Greencore Group | Trading Statement |
Intermediate Capital Group | Trading Statement |
Luceco | Trading Statement |
Wednesday 30 January | |
Wizz Air | Q3 Results |
Staffline Group | Full Year Results |
Aukett Swanke | Full Year Results |
Low & Bonar | Full Year Results |
Thursday broker round-up
(ShareCast News) - Astrazeneca: Berenberg reiterates buy with a target price of 5600p. Legal & General: RBC maintains outperform with a 300p target. Lloyds: JP Morgan reiterates neutral with a 62p target. Centamin: RBC stays at speculative risk with a 190p target. Staffline: Berenberg reiterates
Read more